John D. Morberg - 01 Jun 2023 Form 4 Insider Report for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

Role
Chief Financial Officer
Signature
/s/ Aaron Perlitsh, Attorney-In-Fact for John Morberg
Issuer symbol
LFCR
Transactions as of
01 Jun 2023
Net transactions value
$0
Form type
4
Filing time
05 Jun 2023, 15:24:12 UTC
Previous filing
15 Aug 2022
Next filing
22 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFCR Common Stock Award +45,000 +232% 64,400 01 Jun 2023 Direct F1, F2
transaction LFCR Common Stock Award +50,000 +78% 114,400 01 Jun 2023 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
F2 Restricted Stock Units will vest on the 3rd anniversary of the grant date.
F3 Restricted Stock Units will vest on the 3rd anniversary of the grant date or if earlier, upon a Change in Control.